J. Lipoprotein (a) profile in HIV-1 infected patients treated with highly active antiretroviral therapy (HAART),
Lien de l'article:
Auteur(s): E. KABRE
Auteur(s) tagués: Elie KABRE ;
Résumé

Lipoprotein (a)[Lp (a)] is recognized as an independent factor of arteriosclerosis. The aim of this study was to appreciate the profile of Lipoprotein (a) recognized as an independent factor of arteriosclerosis in the monitoring of HIV-infected patients receiving Nevirapine (NVP) regimens, an antiretroviral known to reduce cardiovascular disease risk. The study population (136 subjects) comprise of 106 HIV-infected subjects, and 30 HIV-negative individuals. The 106 HIV-infected subjects were divided into groups as follows. HAART-untreated (27), HIV-infected subjects that did not receive antiretroviral treatment; HAART-6M (36), HIV-infected subjects on antiretroviral treatment for six months; and HAART-12M (43), HIV-infected subjects on antiretroviral treatment for twelve months. All recruited patients had normal blood lipids values (Total cholesterol< 5.2 mmol/L, Triglycerides< 2 g/L, HDLc> …

Mots-clés

962
Enseignants
5577
Publications
49
Laboratoires
84
Projets